Amylin alters human brain pericyte viability and NG2 expression

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 4, 2017, Pages 1470-1482

  Schultz, Nina ^a   Byman, Elin ^a   Fex, Malin ^b   Wennström, Malin ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY DIABETES CENTRE   (Sweden)

Author keywords

Alzheimer s disease; Cell death mechanisms; Diabetes; Hippocampus; Pericytes

Indexed keywords

AMYLIN; CASPASE 3; CASPASE 7; LACTATE DEHYDROGENASE; OLIGOMER; PROTEOGLYCAN; ANTIGEN; CHONDROITIN SULFATE PROTEOGLYCAN 4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPHAGY; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN PERICYTE; CELL DEATH; CELL INCLUSION; CLINICAL ARTICLE; CYTOTOXICITY ASSAY; DEMENTIA; DIABETES MELLITUS; DISEASE COURSE; ELECTROCHEMILUMINESCENCE; FEMALE; FETUS BRAIN; GENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYSOSOME; MALE; MICROSCOPY; MIDDLE AGED; NEUROPATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OLIGODENDROCYTE PROGENITOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; VERY ELDERLY; WESTERN BLOTTING; BIOSYNTHESIS; CASE CONTROL STUDY; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; MICROVASCULATURE; PATHOLOGY; PERICYTE; VASCULARIZATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIGENS; AUTOPHAGY; CASE-CONTROL STUDIES; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; ISLET AMYLOID POLYPEPTIDE; MALE; MICROVESSELS; MIDDLE AGED; PERICYTES; PROTEOGLYCANS;

EID: 85026324171     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16657093     Document Type: Article

References (40)

1. Jackson K, Barisone GA, Diaz E, et al. Amylin deposition in the brain: A second amyloid in Alzheimer disease? Ann Neurol 2013; 74: 517-526.
2. Konarkowska B, Aitken JF, Kistler J, et al. The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J 2006; 273: 3614-3624.
3. Hoppener JW, Ahren B and Lips CJ. Islet amyloid and type 2 diabetes mellitus. New Engl J Med 2000; 343: 411-419.
4. Rivera JF, Gurlo T, Daval M, et al. Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic beta-cells: protective role of p62-positive cytoplasmic inclusions. Cell Death Different 2011; 18: 415-426.
5. Tucker HM, Rydel RE, Wright S, et al. Human amylin induces “apoptotic” pattern of gene expression concomitant with cortical neuronal apoptosis. J Neurochem 1998; 71: 506-516.
6. Rumora L, Hadzija M, Barisic K, et al. Amylin-induced cytotoxicity is associated with activation of caspase-3 and MAP kinases. Biol Chem 2002; 383: 1751-1758.
7. Janson J, Ashley RH, Harrison D, et al. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 1999; 48: 491-498.
8. Banks WA, Kastin AJ, Maness LM, et al. Permeability of the blood-brain barrier to amylin. Life Sci 1995; 57: 1993-2001.
9. Becskei C, Riediger T, Zund D, et al. Immunohistochemical mapping of calcitonin receptors in the adult rat brain. Brain Res 2004; 1030: 221-233.
10. Kimura R, MacTavish D, Yang J, et al. Beta amyloidinduced depression of hippocampal long-term potentiation is mediated through the amylin receptor. J Neurosci 2012; 32: 17401-17406.
11. Christopoulos G, Paxinos G, Huang XF, et al. Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain. Can J Physiol Pharmacol 1995; 73: 1037-1041.
12. Srodulski S, Sharma S, Bachstetter AB, Brelsfoard JM, Pascual C, Xie XS, et al. Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin. Mol Neurodegener 2014; 9: 30.
13. Nielsen H, Ek D, Avdic U, et al. NG2 cells, a new trail for Alzheimer’s disease mechanisms? Acta Neuropathol Commun 2013; 1: 7.
14. Brannstrom K, Ohman A, Nilsson L, et al. The N-terminal region of amyloid beta controls the aggregation rate and fibril stability at low pH through a gain of function mechanism. J Am Chem Soc 2014; 136: 10956-10964.
15. Trikha S and Jeremic AM. Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol. J Biol Chem 2011; 286: 36086-36097.
16. Magzoub M and Miranker AD. Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide. FASEB J 2012; 26: 1228-1238.
17. Levine B and Klionsky DJ. Development by selfdigestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6: 463-477.
18. Saafi EL, Konarkowska B, Zhang S, et al. Ultrastructural evidence that apoptosis is the mechanism by which human amylin evokes death in RINm5F pancreatic islet beta-cells. Cell Biol Int 2001; 25: 339-350.
19. Schultz N, Nielsen HM, Minthon L, et al. Involvement of matrix metalloproteinase-9 in amyloid-beta 1-42-induced shedding of the pericyte proteoglycan NG2. J Neuropathol Exp Neurol 2014; 73: 684-692.
20. Ozerdem U, Grako KA, Dahlin-Huppe K, et al. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 2001; 222: 218-227.
21. Yousif LF, Di Russo J and Sorokin L. Laminin isoforms in endothelial and perivascular basement membranes. Cell Adhes Migrat 2013; 7: 101-110.
22. Hawkes CA and McLaurin J. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A 2009; 106: 1261-1266.
23. Glick D, Barth S and Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol 2010; 221: 3-12.
24. Kroemer G, Galluzzi L, Vandenabeele P, et al. Classification of cell death: recommendations of the nomenclature committee on cell death 2009. Cell Death Different 2009; 16: 3-11.
25. Trikha S and Jeremic AM. Distinct internalization pathways of human amylin monomers and its cytotoxic oligomers in pancreatic cells. PloS One 2013; 8: e73080.
26. Kayed R, Head E, Thompson JL, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003; 300: 486-489.
27. Bell RD, Deane R, Chow N, et al. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat Cell Biol 2009; 11: 143-153.
28. Mizushima N, Yoshimori T and Levine B. Methods in mammalian autophagy research. Cell 2010; 140: 313-326.
29. Kumar V, Abbas AK, Aster JC, et al. Robbins basic pathology. Philadelphia, PA: Elsevier/Saunders, 2013.
30. Shigihara N, Fukunaka A, Hara A, et al. Human IAPPinduced pancreatic beta cell toxicity and its regulation by autophagy. J Clin Invest 2014; 124: 3634-3644.
31. Morita S, Sakagashira S, Shimajiri Y, et al. Autophagy protects against human islet amyloid polypeptide-associated apoptosis. J Diab Invest 2011; 2: 48-55.
32. Maus F, Sakry D, Biname F, et al. The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2. PloS One 2015; 10: e0137311.
33. Winkler EA, Sagare AP and Zlokovic BV. The pericyte: a forgotten cell type with important implications for Alzheimer’s disease? Brain Pathol 2014; 24: 371-386.
34. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci 2011; 12: 723-738.
35. Marchesi VT. Alzheimer’s dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J 2011; 25: 5-13.
36. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008; 57: 178-201.
37. Sengillo JD, Winkler EA, Walker CT, et al. Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer’s disease. Brain Pathol 2013; 23: 303-310.
38. Biessels GJ and Kappelle LJ. Increased risk of Alzheimer’s disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 2005; 33(Pt 5): 1041-1044.
39. Exalto LG, Biessels GJ, Karter AJ, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diab Endocrinol 2013; 1: 183-190.
40. Berhanu WM, Yasar F and Hansmann UH. In silico cross seeding of Abeta and amylin fibril-like oligomers. ACS Chem Neurosci 2013; 4: 1488-1500.